Applied DNA Sciences, Inc. ( APDN) - Key Metrics
Stock symbol APDN is outdated, potentially delisted? Maybe it is available on other exchange?
APDN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q3 | $0.53 | -$6.90 | -$4.92 | -$4.94 |
| 2025Q2 | $0.55 | -$15.35 | -$1.80 | -$1.90 |
| 2025Q1 | $0.04 | -$0.08 | -$0.11 | -$0.11 |
| 2024Q4 | $0.05 | -$0.19 | -$0.18 | -$0.20 |
| 2024Q3 | $0.20 | $0.47 | -$0.87 | -$0.88 |
APDN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q3 | ? | -0.19 |
| 2025Q2 | -142.62% | -0.41 |
| 2025Q1 | ? | -456.77 |
| 2024Q4 | -4.71% | -655.71 |
| 2024Q3 | ? | 218.22 |
APDN Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q3 | -95.97% | ? |
| 2025Q2 | -7.63% | 87.94% |
| 2025Q1 | -0.07% | ? |
| 2024Q4 | -0.04% | 0.00% |
| 2024Q3 | -0.21% | ? |
APDN
Price: $4.27
52 week price:
Payout Ratio Range:
Earnings Per Share: -57.12 USD
P/E Ratio: -0.07
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 276529
Ebitda: -5.5 millionMarket Capitalization: 2.2 million